Skip to main content
Publications
Reed S, Getahun D, Gatz J, Armstrong M, Raine-Bennett T, Zhou X , Fassett M, Peipert J, Saltus CW , Im T, Alabaster A, Hunter S, Takhar H, Chillemi G, Xie F, Wang J , Chiu V, Frenz A, Shi J, Lynen R, Asiimwe A, Anthony MS . Postpartum timing of IUD insertion is associated with risk of uterine perforation: results from APEX IUD . Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):302. doi: 10.1016/j.contraception.2020.07.099
Raine-Bennett TR, Gatz JL, Reed SD, Armstrong MA, Getahun D, Zhou X , Merchant M, Takhar HS, Ichikawa LE, Peipert JF, Saltus CW , Fassett MJ, Chillemi GA, Im TM, Lynen R, Shi JM, Wang J , Xie F, Hunter S, Chiu VY, Asiimwe A, Anthony MS . Postpartum timing of IUD insertion is associated with risk of IUD expulsion: results from APEX IUD . Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):295-6.
Reed SD, Armstrong MA, Getahun D, Gatz JL, Raine-Bennett TR, Alabaster AL, Ichikawa L, Saltus CW , Xie F, Zhou X , Fassett MJ, Peipert JF, Merchant M, Chiu VY, Hunter S, Schoendorf J, Shi JM, Chillemi GA, Im TM, Takhar HS, Asiimwe A, Anthony MS . Risk of uterine perforation and expulsion associated with breastfeeding among postpartum women with an intrauterine device insertion: results from APEX IUD . Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):297.
Matharu M, Pascual J, Nisson Remahl I, Straube A, Lum A, Davar G, Odom D , Bennett L , Proctor C, Gutierrez L , Andrews E, Johannes C . Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe . Cephalalgia. 2017 Dec;37(14):1384-97. doi: 10.1177/0333102417724150
Matharu M, Pascual J, Nilsson Remahl L, Straube A, Johannes C , Odom D , Gutierrez L , Andrews E, Lum A. Interim analysis of the real-world utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine in an observational study in the European Union . Poster presented at the International Headache Conference; May 14, 2015. Valencia, Spain. [abstract] Cephalalgia. 2015; 35(6S):39.